Publications
Research Papers Published
- "Evaluation of Hepatoprotective Potential of Swertia tetragona Edgew" IOSR Journal of Pharmacy and Biological Sciences, 12(05): DOI No. 10.9790/3008-1205021728 {ISSN: 2278-3008} Impact Factor=
- "Effectiveness and safety of ferric
carboxymaltose compared to iron sucrose
in women with iron deficiency anemia:
phase IV clinical trials" BMC Womens Health, 18(6): 01 -10 Impact Factor= 2.0
- "Phytochemical, Antibacterial, Antiinflammatory And Analgesic
Studies On Swertia Tetragona Edgew" IOSR Journal of Pharmacy and Biological Sciences (IOSR
-
JPBS), 13(1): 41 -50 {ISSN: 2319 - 767} Impact Factor=
- "Antimicrobial Potential and Determination of Total Phenolic and Flavonoid Content of Aerial Part Extracts of Ajuga bracteosa Wall ex. Benth" Pharmacognosy Communications, 8(3): 114 -118 Impact Factor=
- "Influence of Iron Deficiency Anemia on
HbA1c: A Review" Current Research in Diabetes & Obesity Journal (CRDOJ), 5(3): 001 -002 Impact Factor= 0.55
- "Pharmacognostical standardization, Phytochemical investigation & anthelmintic activity if Arisaema propinquum Schott rhizome" Pharmacognosy Research, 12(02): DOI No. 10.4103/pr_106_19 Impact Factor=
- "Evaluation of Antiarthritic Potential of Arisaema propinquum Schott Rhizome against complete freund's adjuvant arthritic rats" Annals of Pharmacology & Pharmaceutics, 05(02): 1180 -1188 Impact Factor=
- "Prevalence of high risk obstructive sleep apnoea by Berlin questionnaire in patients with hypertension: study from a tertiary care hospital" Sleep Science and Practice, 04(15): 01 -09 Impact Factor=
- "Polycystic ovarian syndrome-Current Pharmacotherapy and clinical implications" Taiwanese Journal of Obstetrics and Gynecology, 61(1): 40 -50 {ISSN: 1028-4559} Impact Factor= 1.705
- "Imidazopyridine, a promising scaffold with
potential medicinal applications and structural
activity relationship (SAR): recent advances" Journal of Biomolecular Structure and Dynamics, 39(1): 1 -24 {ISSN: 1538-0254} Impact Factor= 3.49
- "Obstructive sleep apnoea and metabolic syndrome" Sleep and Vigilence, 5(01): DOI No. 01 {ISSN: 2510220} Impact Factor= 2.29
- "Polycystic ovarian syndrome-Current Pharmacotherapy and clinical implications" Taiwanese Journal of Obstetrics and Gynecology, 61(02): 40 -50 {ISSN: 322-453} Impact Factor= 1.95
- "Role of
Nanotechnology in Overcoming the
Multidrug Resistance in Cancer
Therapy" Molecules, 27(6608): DOI No. 01 {ISSN: 1420-3049} Impact Factor= 4.927
- "Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial" Medicina, 58(11): DOI No. 01 {ISSN: 1648-9144} Impact Factor= 2.948
- "Optimizing the fabrication of electrospun nanofibers of prochlorperazine for enhanced dissolution and permeation properties" Biomaterials Advances, 158(1): DOI No. 213773 {ISSN: 2772-9508} Impact Factor= 7.9
- "Flavonoids as promising molecules in the cancer therapy: An insight" Current Research in Pharmacology and Drug Discovery, 6(1): DOI No. 100167 {ISSN: 2590-2571} Impact Factor= 2.9
- "Recent Advances in the Pharmacological Properties and Molecular Mechanisms of Carvacrol" Rev. Bras. Farmacogn, 34(1): 35 -47 {ISSN: 1981-528X} Impact Factor= 2.46
- "Exploring the mTOR signalling pathway and its inhibitory scope in cancer" Pharmaceuticals, 16(7): DOI No. 1004. {ISSN: 1424-8247} Impact Factor= 4.6
- "An Insight into the Global Problem of Gastrointestinal Helminth Infections amongst Livestock: Does Nanotechnology Provide an Alternative?" Agriculture, 13(1): DOI No. 1359 {ISSN: 2077-0472} Impact Factor= 3.65
- "Naringenin improves ovarian health by reducing the serum androgen and eliminating follicular cysts in letrozole-induced polycystic ovary syndrome in the Sprague Dawley rats" Phytotherapy Research, 37(9): 4018 -4041 {ISSN: 1099-1573} Impact Factor= 7.2
- "Thiamine deficiency in pregnancy and lactation: implications and present perspectives" Front. Nutr, 10(1): DOI No. 1080611 {ISSN: 2296-861X} Impact Factor= 5.0
- "Prevalence of Thiamine Deficiency in Pregnancy and its impact on fetal outcome in an area endemic for thiamine deficiency" PLOS Neglected Tropical Diseases, 17(5): DOI No. e0011324 {ISSN: 1935-2727} Impact Factor= 4.78
- "Attenuation of
Paracetamol-induced hepatotoxicity in Ajuga bracteosaextract treated mice." Heliyon, 10(13): 01 -14 {ISSN: 2405-8440} Impact Factor= 4.0
- "Unravelling therapeutic potential and nano formulation approachesof farnesol, a bioactive sesquiterpene" Advances in Traditional Medicine, 06(01): 01 -19 {ISSN: 2662-4060} Impact Factor= 1.8
- "Optimizing the fabrication of electrospun nanofibers of prochlorperazine for enhanced dissolution and permeation properties" Biomaterials Advances, 158(1): 01 -12 {ISSN: 2772-9508} Impact Factor= 7.62
- "Molecular docking and dynamics simulation of farnesol as a potentialanticancer agent targeting mTOR pathway" In Silico Pharmacology, 12(89): 01 -11 {ISSN: 2193-9616} Impact Factor= 0.0
- "Ciprofloxacin hydrochloride-loaded ocular silk fibroin liposomes:Formulation, characterisation, in vitro cytotoxicity, andantimicrobial activity" Heliyon, 10(1): 01 -12 {ISSN: 2405-8440} Impact Factor= 4.0
- "In-vitro antioxidant and anti-proliferativeactivity of aerial parts of Senecio Laetus Edgewon breast cancer (MCF-7) and colon carcinoma(HCT116) cell lines" BMC Complementary Medicine and Therapies, 25(45): 01 -14 {ISSN: 2662-7671} Impact Factor= 3.6
- "Farnesol-loaded Silver Nanoparticles as a Potent Nanotherapeutic Agent Against Colon and Breast Cancer" BioNanoScience, 16(04): DOI No. 10.1007/s12668-026-02427-6 {ISSN: 2191-1649} Impact Factor= 3.5
- "“Integrating in-silico and experimental validation approaches to unveil the therapeutic mechanism of naringenin against breast cancer, October 2025," Scientific Reports, 15(01): DOI No. 10.1038/s41598-025-19931-6 {ISSN: 2045-2322} Impact Factor= 3.9
- "“Piperine-induced AMPK activation and cell cycle arrest: insights from molecular simulations and experimental validation in breast cancer”" Medical Oncology, 43(04): DOI No. DOI: 10.1007/s12032-026-03261- {ISSN: 1559-131X} Impact Factor= 3.5
- "“Naringenin Inhibits Cellular Proliferation, Arrests Cell Cycle and Induces Pro-Apoptotic Autophagy in MCF-7 Breast Cancer Cells”, August 2025," Journal of Cellular and Molecular Medicine 29(15), 29(15): DOI No. DOI: 10.1111/jcmm.70747 {ISSN: 1582-49341} Impact Factor= 4.2
- "“Harnessing piperine: Pharmacological potential and novel nanoformulation approaches”" Next Research, 4(101231): DOI: 10.1016/j.nexres.2025.101 -0 {ISSN: 3050-4759} Impact Factor=
- "Comparative study of Thiopentone and Propofol for induction of anaesthesia in adult population- a randomized clinical trial" Perioperative Care and Operating Room Management, 40(100513): https://doi.org/10.1016/j.pcor -0 {ISSN: 2405-6030} Impact Factor= 1.0
- "Phytochemical Profiling and Anthelmintic Potential of Rhizome of Swertia petiolata Against Haemonchus contortus: An Integrated In Vitro and In Silico Approach" Veterinary parasitology, 344(110763): DOI: https://doi.org/10.1016/j -0 {ISSN: 0304-4017} Impact Factor= 2.2
Books Published
- "Quality control of Cellular protein in Neurodegenerative disorders:Chapter 9: Beclin-1 complex & neurodegenerative disorders". IGI Global Publishers. pp 30
- "Nanotechnology and Diabetes Management: Recent Advances and Future Perspectives". Springer, singapore. {ISBN: 978-981-15-5621-0} pp 18
- "Edible Plants in Health and Diseases Vol 1: Medicinal plants and their contribution in Socio-economic upliftment of the household in Gurez valley.". Springer nature- Singapore. {ISBN: 978-981-16-4879-3} pp 29
- "Edible Plants in Health & Disease Vol:2; Positive Health benefits of Saponins from Edible legumes". Springer nature- Singapore. {ISBN: 978-981-16-4958-5} pp 29
- "Edible Plants in Health and Diseases Vol 2: Arctium Lappa: A Review on its phytochemistry and pharmacology". Springer nature- Singapore. {ISBN: 978-981-16-4958-5} pp 22
- "“Anticancer Activity of Natural Compounds” Bioactive Ingredients for Healthcare Industry (2025) Volume 2, DOI: 10.1007/978-981-96-4379-06". Springer-Nature, DOI: 10.1007/978-981-96-4379-06. {ISBN: 978-981-96-4378-3 (H} pp 28
- "Mechanism of Alkaloids and Flavonoids in Regulating Diabetes in "Bioactive Ingredients for Healthcare Industry Volume 2"". Springer-Nature, DOI: 10.1007/978-981-96-4379-0_10. {ISBN: 978-981-96-4378-3} pp 20
- "“Endometrial and placental dysfunction in recurrent pregnancy loss” in Book: Reproductive Immunogenetics: A Molecular and Clinical Overview, volume III, Edition: Volume III, Chapter: 7". Elsevier. {ISBN: 9780443136573} pp 29
- "“Bladder cancer: PI3K/Akt/mTOR signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives” in Book: Proteomics: A Promising Approach for Cancer Research,". Elsiever Inc, DOI: 10.1016/B978-0-443-23908-3.00018-6.. {ISBN: 9780443239083 .} pp 31
- "“Colorectal cancer: Notch signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives”, Book: Proteomics: A Promising Approach for Cancer Research". Academic Press, Elsivier Inc., DOI: 10.1016/B978-0-443-23908-3.00002-2. {ISBN: 0323950728} pp 46
- "“Role of MAPK signaling pathway in recurrent pregnancy loss”, book: Reproductive Immunigenetics: A molecular and Clinical Overview, Chapter: 12". Academic Press, Elsevier Inc. {ISBN: 9780443136573,} pp 18